News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Chiara Corti: DESTINY-Breast06 results presented by G Curigliano
Photo taken from Chiara Corti/X
Jun 4, 2024, 12:43

Chiara Corti: DESTINY-Breast06 results presented by G Curigliano

Chiara Corti, Research Fellow at Dana-Farber Cancer Institute, shared a post on X:

“DESTINY-Breast06 results presented by G Curigliano.

T-DXd showed efficacy also as 1st line cytotoxic agent in HR and HER2low (n=713) and UltraLow (n=153) mBC. 11% ILD (3 g5).”

Chiara Corti

Source: Chiara Corti/X

ASCO ASCO24 cancer Chiara Corti cytotoxic agent Dana-Farber Cancer Institute DESTINY-Breast06 G Curigliano OncoDaily Oncology
Blog
Jun 29, 2024, 23:07
Richi Childhood Cancer Foundation launches a new series Faces of Hope at the Richi House
Blog
Jun 29, 2024, 22:54
Caitlin Delaney: The reality of living with a rare cancer
Blog
Jun 29, 2024, 22:45
Improve your digital skills for better patient care with transition - European Cancer Organisation
Blog
Jun 29, 2024, 22:31
Novocure is looking for Regional Business Director, US CNS (Northeast)
Blog
Jun 29, 2024, 18:30
Anil D'Cruz: Need government legislation to decrease tobacco consumption
Blog
Jun 29, 2024, 17:42
Fantastic updates about treating intermediate-risk neuroblastoma - St. Baldrick’s Foundation
Insight
Jun 29, 2024, 16:57
MD Anderson Research Highlights: EHA 2024 Special Edition
Blog
Jun 29, 2024, 16:49
ESMO - IARC webinar on Epidemiological and Clinical Research on Cancer Survival and Outcome
Blog
Jun 29, 2024, 16:41
Mandy Lauw: Mentorship speed dating and kick-start of the Cancer Institute mentorship program
Insight
Jun 29, 2024, 16:24
Anand Patel: Highlighting challenges in MPNs at SOHO 2024
Blog
Jun 29, 2024, 16:09
Daniel Stover: Real world studies versus negative clinical trials
Insight
Jun 29, 2024, 15:42
Timir Paul: Learned ‘permissive cardio toxicity’ from Eric Young